Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Kraig Biocraft Laboratories, Inc.(KBLB) the EBIT is -703.43 K (-10.3%);the EPS is -0.0008 (-18.18%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B10.30%
----
----
EPS
-0.000818.18%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf